Equities

Bio-Techne Corp

Bio-Techne Corp

Actions
Health CareMedical Equipment and Services
  • Price (USD)71.35
  • Today's Change0.297 / 0.42%
  • Shares traded347.40k
  • 1 Year change+12.22%
  • Beta1.2600
Data delayed at least 15 minutes, as of Nov 22 2024 20:07 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Jun 30 2024202420232022
ASSETS
Cash And Short Term Investments153204247
Total Receivables, Net241218195
Total Inventory180172141
Prepaid expenses------
Other current assets, total432723
Total current assets617621606
Property, plant & equipment, net342325289
Goodwill, net973873822
Intangibles, net507535532
Long term investments------
Note receivable - long term------
Other long term assets26428547
Total assets2,7042,6392,295
LIABILITIES
Accounts payable382634
Accrued expenses886392
Notes payable/short-term debt000
Current portion long-term debt/capital leases--013
Other current liabilities, total344038
Total current liabilities159129176
Total long term debt319350243
Total debt319350256
Deferred income tax568999
Minority interest--0(0.76)
Other liabilities, total10110575
Total liabilities635672593
SHAREHOLDERS EQUITY
Common stock1.581.580.39
Additional paid-in capital820722654
Retained earnings (accumulated deficit)1,3251,3091,123
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(78)(66)(75)
Total equity2,0691,9671,702
Total liabilities & shareholders' equity2,7042,6392,295
Total common shares outstanding158158157
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.